tailieunhanh - Safety of infusing rituximab at a more rapid rate in patients with rheumatoid arthritis: Results from the RATE-RA study

As recommended in the current prescribing information, rituximab infusions in patients with rheumatoid arthritis (RA) take hours for the first infusion and hours for subsequent infusions, which is a burden on patients and the health care system. |